Over the past several years there has been increasing reports of JAK inhibitors being used to treat recalcitrant alopecia areata with excellent results in the majority of patients. Currently it is being explored as a potential topical treatment option for treating alopecia areata as well. Overall patients and JAK inhibitors do well with minimal to no side effects but there are portentially serious medical side effects that can occur. Currently, it is not covered by insurance nor FDA approved for alopecia areata. Hopefully, in the near future with more positive data, it will be approved and be an important new treatment option for patients with this devastating hair loss condition.
Below is a copy of our office handout that we would give to patients who are interested in taking oral minoxidil for their hair loss.
Overview of some of the innovative therapeutic tools that can be used to slow hair loss and increase hair growth.
Observational study on the high incidence of Androgenetic Alopecia among patients hospitalized due to severe COVID-19
In 2021, the American Board of Dermatology has established a Micrographic Dermatologic Surgery Subspecialty Certification Examination. Dr. David Avram is proud to be part a certified member of this subspecialty which is such an important part of our field
Dr. Marc Avram is proud to author the first series of CME (continuing medical education) articles on hair transplantation for a leading journal for dermatology.
Johnson & Johnson recalls Aveeno, Neutrogena Spray Sunscreens